Metabolomic Profiling Identifies Early Biomarkers of Frailty, Balance Impairment, and Fall Risks in Older Adults
Gerontology · 2025
DOI: 10.1159/000546772 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gerontology, 2025. Verfasst von Alina Zhawatibai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Frailty, Metabolomics, Accidental Falls, Postural Balance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Introduction
The global aging population poses significant challenges to healthcare, with frailty, balance impairment, and fall risks being prominent issues. However, the conventional clinical assessments often fail to detect early signs of these conditions. This study aimed to explore the potential of metabolomics in early identification of biomarkers related to frailty, poor balance, and fall risks in older adults.
Methods
We analyzed plasma samples from 110 participants aged 25–98 years using untargeted metabolomic analysis. Clinical assessments, including Instrumental Activities of Daily Living (IADL), Morse Fall Risk Scale, Timed Up and Go (TUG), and Fried Frailty Criteria, were performed. We examined the correlation between metabolomic results, aging-related blood tests, and clinical assessments. Statistical analysis and pathway analysis were used to identify key metabolic alterations.
Results
The metabolomics analysis identified 914 metabolites matching in the human metabolome database, with 293 metabolites significantly correlated with age. Metabolomic profiles showed distinct alterations in older adults, with significant metabolic changes observed in the old-old group, particularly in pathways related to lipid metabolism, sphingolipid signaling, and fatty acid metabolism. A new age classification based on metabolic profiles revealed significant differences in frailty risks across groups, with metabolic signatures linked to poor balance and fall risks.
Conclusion
Metabolomics offers a promising approach to identify early biomarkers of frailty, balance impairment, and fall risks in older adults. The integration of metabolic profiles with clinical assessments could lead to more precise and personalized healthcare interventions, improving fall prevention strategies and frailty management. Future studies with larger cohorts are needed to validate these findings and explore the clinical utility of Metabolomics in aging-related healthcare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Rehabilitation Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Shenzhen Mass Medical Co. Ltd., Shenzhen, China, mxzhouhe@hotmail.com.
- JiangXi Key Laboratory of Transfusion Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Zitieren
APA
Zhawatibai, A., Liu, H., Xie, A., Zhou, H., Jiang, J., Yuan, N., Wang, J., Dan, C., Li, S., & Wang, S. (2025). Metabolomic Profiling Identifies Early Biomarkers of Frailty, Balance Impairment, and Fall Risks in Older Adults. Gerontology. https://doi.org/10.1159/000546772
Vancouver
Zhawatibai A, Liu H, Xie A, Zhou H, Jiang J, Yuan N, et al. Metabolomic Profiling Identifies Early Biomarkers of Frailty, Balance Impairment, and Fall Risks in Older Adults. Gerontology. 2025. doi:10.1159/000546772
BibTeX
@article{Zhawatibai2025,
author = {Zhawatibai, Alina and Liu, Huanbing and Xie, An and Zhou, He and Jiang, Jingwei and Yuan, Na and Wang, Jun and Dan, Chuancai and Li, Sujun and Wang, Shu},
title = {Metabolomic Profiling Identifies Early Biomarkers of Frailty, Balance Impairment, and Fall Risks in Older Adults},
journal = {Gerontology},
year = {2025},
doi = {10.1159/000546772}
}
EUVIMED